IL100889A - Nootropic and nerve- regenerative pharmaceutical compositions comprising 4-(7-bromo- 5-methoxybenzofuran-2-yl) piperidine - Google Patents

Nootropic and nerve- regenerative pharmaceutical compositions comprising 4-(7-bromo- 5-methoxybenzofuran-2-yl) piperidine

Info

Publication number
IL100889A
IL100889A IL100889A IL10088992A IL100889A IL 100889 A IL100889 A IL 100889A IL 100889 A IL100889 A IL 100889A IL 10088992 A IL10088992 A IL 10088992A IL 100889 A IL100889 A IL 100889A
Authority
IL
Israel
Prior art keywords
methoxybenzofuran
piperidine
bromo
nerve
nootropic
Prior art date
Application number
IL100889A
Other versions
IL100889A0 (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL100889A0 publication Critical patent/IL100889A0/en
Publication of IL100889A publication Critical patent/IL100889A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

A pharmaceutical composition for retarding the degeneration of nerve cells that accompanies degenerative nerve disorders, and for use as a nootropic agent, which composition comprises 4-(7-bromo-5-methoxybenzofuran-2-yl) piperidine of the formula CH3OBrONH or a pharmaceutically acceptable salt thereof.
IL100889A 1991-02-15 1992-02-06 Nootropic and nerve- regenerative pharmaceutical compositions comprising 4-(7-bromo- 5-methoxybenzofuran-2-yl) piperidine IL100889A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH47091 1991-02-15

Publications (2)

Publication Number Publication Date
IL100889A0 IL100889A0 (en) 1992-11-15
IL100889A true IL100889A (en) 1997-03-18

Family

ID=4187740

Family Applications (1)

Application Number Title Priority Date Filing Date
IL100889A IL100889A (en) 1991-02-15 1992-02-06 Nootropic and nerve- regenerative pharmaceutical compositions comprising 4-(7-bromo- 5-methoxybenzofuran-2-yl) piperidine

Country Status (16)

Country Link
EP (1) EP0499586B1 (en)
JP (1) JPH0570352A (en)
KR (1) KR920016098A (en)
AT (1) ATE138805T1 (en)
AU (1) AU655227B2 (en)
CA (1) CA2061015A1 (en)
DE (1) DE59206442D1 (en)
DK (1) DK0499586T3 (en)
ES (1) ES2087497T3 (en)
GR (1) GR3020155T3 (en)
IE (1) IE74906B1 (en)
IL (1) IL100889A (en)
MX (1) MX9200620A (en)
NO (1) NO179358C (en)
NZ (1) NZ241608A (en)
ZA (1) ZA921091B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993016696A1 (en) * 1992-02-21 1993-09-02 Ciba-Geigy Ag Brofaromine as an agent for treating social phobia

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989003692A1 (en) * 1987-10-22 1989-05-05 Massachusetts Institute Of Technology Treating premenstrual or late luteal phase syndrome

Also Published As

Publication number Publication date
DE59206442D1 (en) 1996-07-11
IE74906B1 (en) 1997-08-13
DK0499586T3 (en) 1996-06-24
KR920016098A (en) 1992-09-24
ES2087497T3 (en) 1996-07-16
IL100889A0 (en) 1992-11-15
EP0499586B1 (en) 1996-06-05
NZ241608A (en) 1997-06-24
AU1087792A (en) 1992-08-20
NO179358B (en) 1996-06-17
MX9200620A (en) 1992-08-01
NO920591D0 (en) 1992-02-14
NO179358C (en) 1996-09-25
AU655227B2 (en) 1994-12-08
JPH0570352A (en) 1993-03-23
IE920486A1 (en) 1992-08-26
NO920591L (en) 1992-08-17
EP0499586A1 (en) 1992-08-19
GR3020155T3 (en) 1996-09-30
ATE138805T1 (en) 1996-06-15
ZA921091B (en) 1992-09-30
CA2061015A1 (en) 1992-08-16

Similar Documents

Publication Publication Date Title
IL114599A (en) Substituted pyrimidine compounds their preparation and pharmaceutical compositions containg them
UA39168C2 (en) Fluoroalkoxyphenyl derivatives of pyperidine or quinuclidine AS antagonists of P substance and pharmaceutical composition based thereon
NZ247201A (en) Substituted sulphonylamido- or sulphonamidocarbonyl-pyridine-2-carboxamide derivatives and pharmaceutical compositions
CA2093798A1 (en) Pyridine and pyridine n-oxide derivatives of diaryl methyl piperidines or piperazines, and compositions and methods of use thereof
IL149163A0 (en) Piperazine derivatives of carbazole, their preparation and pharmaceutical compositions containing them
FI961809A (en) Novel (R) -5-carbamoyl-8-fluoro-3-N, N-disubstituted amino 3,4-dihydro-2H-1-benzopyrans
BG103195A (en) Substituted indazole derivatives and their application as inhibitors of phosphodiesterase (pde) type iv and of the production of a tumournecrotic factor (tnf)
DK0894084T3 (en) Cinnamic acid derivatives and their use as integrin antagonists
IL114894A (en) Pyrrolidine derivatives as endothelin antagonists, pharmaceutical compositions containing them, and their use in the preparation of medicaments
WO1999020606A3 (en) Piperidines and piperazines as platelet aggregation inhibitors
ZA948670B (en) New benzoyl guanidine derivatives,the preparation thereof and their use in pharmaceutical compositions
ES8601965A1 (en) Novel ((bis(aryl)methylene)-1-piperidinyl)alkyl-pyrimidinones.
AU3495397A (en) Muscarinic antagonists
GB8904163D0 (en) Piperazine derivative or its sait,process for producing the same and pharmaceutical composition comprising the same as active ingredient
TW327601B (en) Compositions for use in inhibiting uterine fibrosis
ES2087038A1 (en) Novel piperidine derivatives with paf antagonist activity
WO1992014696A3 (en) SUBSTITUTED α-AMINOALDEHYDES AND DERIVATIVES
MX9403088A (en) Indole derivatives.
MX9704034A (en) Substituted 2-arylcarbonyloxymethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives and compositions and method of use thereof.
BG102661A (en) Benzo/o/quinolysine derivatives, their preparation and application as 5a-reductase inhibitors
IL100889A (en) Nootropic and nerve- regenerative pharmaceutical compositions comprising 4-(7-bromo- 5-methoxybenzofuran-2-yl) piperidine
BG102229A (en) Endothelium receptor antagonists
WO1993005807A3 (en) Erythropoietin potentiating agents and methods for their use
AP9200443A0 (en) Heterocyclic compounds.
ES8504774A1 (en) 2-piperazinyl-quinazoline derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees